| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kura Oncology, Inc. (KURA) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 2 sells. KURA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 275.5K | $2.85M | - | |
| Other | 185.0K | $1.92M | - | |
| Other | 100.0K | $1.04M | - | |
| Other | 100.0K | $1.04M | - | |
| COO | 100.0K | $1.04M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2019 | Gualberto Antonio | Head Of Development &CMO | Sale+OE | 18,000 | $21.11 | $379,902.60 | -5.0% | |
| Dec 21, 2018 | Ecor1 Capital Fund Qualified, L.P. | 10% Owner | Buy | 213,888 | $13.57 | $2,901,833.34 | +1.7% | |
| Dec 17, 2018 | Ecor1 Capital Fund Qualified, L.P. | 10% Owner | Sell | 26,520 | $13.20 | $350,064.00 | -0.6% | |
| Dec 13, 2018 | Ecor1 Capital Fund Qualified, L.P. | 10% Owner | Buy | 40,538 | $13.90 | $563,362.39 | +0.5% | |
| Dec 6, 2018 | Ecor1 Capital Fund Qualified, L.P. | 10% Owner | Buy | 119,906 | $13.50 | $1,618,254.85 | +1.0% | |
| Nov 10, 2015 | Malley Thomas67 | Director | Buy | 50,000 | $8.00 | $400,000.00 | +126.4% |